| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 127.012 | 78 |
| GSM780708 | Untreated after 4 days (C2_1) | 102.586 | 76 |
| GSM780709 | Untreated after 4 days (C3_1) | 69.3371 | 69 |
| GSM780719 | Untreated after 4 days (C1_2) | 116.467 | 77 |
| GSM780720 | Untreated after 4 days (C2_2) | 95.0503 | 74 |
| GSM780721 | Untreated after 4 days (C3_2) | 74.2099 | 70 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 96.0191 | 75 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 118.712 | 78 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 122.046 | 78 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 96.0326 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 129.712 | 79 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 115.413 | 77 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 139.352 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 102.529 | 76 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 177.709 | 82 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 148.817 | 80 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 121.128 | 78 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 199.195 | 84 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 81.4478 | 72 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 100.703 | 75 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 93.9211 | 74 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 73.2229 | 70 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 100.752 | 75 |